Our CEO, Jeff Goater, and CMO, Robert Ross, will participate today in the 3rd Annual Evercore ISI Global HealthCONx Conference, where they will discuss our lead programs, SRF617 and SRF388, and our emerging pre-clinical pipeline. Read more here: https://t.co/LU3Sv1Onxk https://t.co/C1YZeJGaFU